Ji-Gan Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ji-Gan Wang has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
Hui-Hong Dou
5 shared publicationsHui‐Hong Dou
3 shared publicationsJiani Zhu
Department of Clinical Nutrition, The First People’s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology
3 shared publicationsYan Li
Department of Pediatrics, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
3 shared publicationsYu-Heng Su
Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
3 shared publicationsFan Yang
Department of Clinical Nutrition, The First People’s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology
2 shared publications
Latest Publications
- Open Access
- 4 September 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (36) , e50515
The role of ferroptosis in juvenile idiopathic arthritis
This study employed a bidirectional 2-step, two-sample Mendelian randomization approach to investigate the causal relationships between ferroptosis-related genes and juvenile idiopathic arthritis (JIA) and to explore the mediating role of immune cells. Ferroptosis genes were identified from the deCODE database and matched with protein quantitative trait locus data as exposures to evaluate their causal effects on JIA, while immune cell traits were similarly assessed. For genes showing positive Mendelian randomization results, further analyses were conducted to determine whether immune cells mediated the effects on JIA, with mediation analysis performed only in the presence of causal associations. Data were sourced from the GWAS, FerrDb, and other public repositories. Nine ferroptosis-related genes were found to have causal links with JIA: HSPB1, DECR1, LIFR, and CTSB increased JIA risk, whereas PIEZO1, DPP4, BID, and others were protective. Forty immune cell traits were also causally associated with JIA. Mediation analysis revealed that several immune cells, including CD127 − CD8 + T cells, partially mediated the genetic effects, with mediation proportions reaching up to 18.6%. Collectively, these results point to a ferroptosis–immune–JIA axis, suggesting that ferroptosis-related genes contribute to JIA pathogenesis through immune cell mediation and offering new mechanistic insights and potential therapeutic targets.
- 4 September 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (36) , e50515
Open AccessThe role of ferroptosis in juvenile idiopathic arthritis
This study employed a bidirectional 2-step, two-sample Mendelian randomization approach to investigate the causal relationships between ferroptosis-related genes and juvenile idiopathic arthritis (JIA) and to explore the mediating role of immune cells. Ferroptosis genes were identified from the deCODE database and matched with protein quantitative trait locus data as exposures to evaluate their causal effects on JIA, while immune cell traits were similarly assessed. For genes showing positive Mendelian randomization results, further analyses were conducted to determine whether immune cells mediated the effects on JIA, with mediation analysis performed only in the presence of causal associations. Data were sourced from the GWAS, FerrDb, and other public repositories. Nine ferroptosis-related genes were found to have causal links with JIA: HSPB1, DECR1, LIFR, and CTSB increased JIA risk, whereas PIEZO1, DPP4, BID, and others were protective. Forty immune cell traits were also causally associated with JIA. Mediation analysis revealed that several immune cells, including CD127 − CD8 + T cells, partially mediated the genetic effects, with mediation proportions reaching up to 18.6%. Collectively, these results point to a ferroptosis–immune–JIA axis, suggesting that ferroptosis-related genes contribute to JIA pathogenesis through immune cell mediation and offering new mechanistic insights and potential therapeutic targets.
- Open Access
- 10 July 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1870650
Thyroid autoimmunity is associated with fertilization impairment and follicular fluid exosomal miRNA alterations in euthyroid women undergoing IVF-ET
Objective: To investigate the impact of thyroid autoimmunity (TAI) on fertilization outcomes in euthyroid infertile women undergoing in vitro fertilization–embryo transfer (IVF-ET), and to identify key follicular fluid exosomal miRNAs associated with TAI. Methods: A total of 4,332 infertile women aged 20–40 years undergoing IVF-ET at the First People’s Hospital of Yunnan Province between January and October 2024 were retrospectively enrolled. TAI was defined as TPOAb >34 IU/mL and/or TgAb >115 IU/mL. Fertilization rates were compared using the Wilcoxon rank-sum test, and the association between TAI and fertilization outcomes was assessed using generalized linear models. For mechanistic analysis, follicular fluid samples from 10 euthyroid TAI-positive and 10 euthyroid TAI-negative women were subjected to exosomal miRNA sequencing. TAI-related miRNAs were identified by integrating WGCNA and differential expression analysis (edgeR), followed by GO and KEGG enrichment analyses. Key miRNAs were screened using LASSO and SVM, and their diagnostic performance was evaluated by ROC analysis. Target genes were predicted using miRWalk and used to construct a miRNA–mRNA regulatory network with subsequent functional enrichment analysis. Results: Among the 4,332 infertile women undergoing IVF-ET, 565 were TAI-positive and 3,767 were TAI-negative. The fertilization rate was significantly lower in the TAI-positive group, and TAI was identified as an independent risk factor for impaired fertilization in euthyroid women. Exosomal miRNA sequencing of follicular fluid identified 70 differentially expressed miRNAs, and 17 candidate miRNAs were obtained by integrating WGCNA results. Further screening using LASSO and SVM identified four key miRNAs: hsa-miR-6799-3p, hsa-miR-6836-3p, hsa-miR-4449, and hsa-miR-3162-5p, all of which demonstrated good diagnostic performance (AUC > 0.7). Functional enrichment analysis of target genes suggested that these miRNAs may be involved in TAI-related reproductive impairment through pathways such as cell–matrix adhesion and mTOR signaling. Conclusion: TAI is independently associated with impaired fertilization outcomes in euthyroid infertile women undergoing IVF-ET and is accompanied by altered expression profiles of follicular fluid exosomal miRNAs. hsa-miR-6799-3p, hsa-miR-6836-3p, hsa-miR-4449, and hsa-miR-3162-5p may serve as potential molecular biomarkers for TAI-related reproductive dysfunction, providing insights into underlying mechanisms and potential diagnostic targets.
- 10 July 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1870650
Open AccessThyroid autoimmunity is associated with fertilization impairment and follicular fluid exosomal miRNA alterations in euthyroid women undergoing IVF-ET
Objective: To investigate the impact of thyroid autoimmunity (TAI) on fertilization outcomes in euthyroid infertile women undergoing in vitro fertilization–embryo transfer (IVF-ET), and to identify key follicular fluid exosomal miRNAs associated with TAI. Methods: A total of 4,332 infertile women aged 20–40 years undergoing IVF-ET at the First People’s Hospital of Yunnan Province between January and October 2024 were retrospectively enrolled. TAI was defined as TPOAb >34 IU/mL and/or TgAb >115 IU/mL. Fertilization rates were compared using the Wilcoxon rank-sum test, and the association between TAI and fertilization outcomes was assessed using generalized linear models. For mechanistic analysis, follicular fluid samples from 10 euthyroid TAI-positive and 10 euthyroid TAI-negative women were subjected to exosomal miRNA sequencing. TAI-related miRNAs were identified by integrating WGCNA and differential expression analysis (edgeR), followed by GO and KEGG enrichment analyses. Key miRNAs were screened using LASSO and SVM, and their diagnostic performance was evaluated by ROC analysis. Target genes were predicted using miRWalk and used to construct a miRNA–mRNA regulatory network with subsequent functional enrichment analysis. Results: Among the 4,332 infertile women undergoing IVF-ET, 565 were TAI-positive and 3,767 were TAI-negative. The fertilization rate was significantly lower in the TAI-positive group, and TAI was identified as an independent risk factor for impaired fertilization in euthyroid women. Exosomal miRNA sequencing of follicular fluid identified 70 differentially expressed miRNAs, and 17 candidate miRNAs were obtained by integrating WGCNA results. Further screening using LASSO and SVM identified four key miRNAs: hsa-miR-6799-3p, hsa-miR-6836-3p, hsa-miR-4449, and hsa-miR-3162-5p, all of which demonstrated good diagnostic performance (AUC > 0.7). Functional enrichment analysis of target genes suggested that these miRNAs may be involved in TAI-related reproductive impairment through pathways such as cell–matrix adhesion and mTOR signaling. Conclusion: TAI is independently associated with impaired fertilization outcomes in euthyroid infertile women undergoing IVF-ET and is accompanied by altered expression profiles of follicular fluid exosomal miRNAs. hsa-miR-6799-3p, hsa-miR-6836-3p, hsa-miR-4449, and hsa-miR-3162-5p may serve as potential molecular biomarkers for TAI-related reproductive dysfunction, providing insights into underlying mechanisms and potential diagnostic targets.
- Open Access
- 21 April 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1776074
Analysis of body composition characteristics in patients with type 1 diabetes mellitus: a case–control study based on a bioelectrical impedance analyzer
Objective: This study aimed to systematically compare differences in body composition between adult patients with type 1 diabetes mellitus (T1DM) and healthy controls using the bioelectrical impedance analysis (BIA) method, to provide an objective basis for clinical nutritional assessment and intervention in T1DM patients. Methods: A total of 57 T1DM patients hospitalized at the First People’s Hospital of Yunnan Province between December 2023 and April 2024 were selected as the study group, and 55 healthy adults matched for age, sex, and BMI were recruited as the control group. Body composition indicators, including body fat, fat-free mass, skeletal muscle, visceral fat area, and phase angle (PA), were measured for all subjects using a body composition analyzer, and the skeletal muscle mass index (SMI) was calculated. BIA was used to determine body composition parameters, and statistical analyses were conducted to compare the differences between the two groups. Results: In males, the T1DM group exhibited significantly lower body fat, body fat percentage, bone mineral content, visceral fat area, and SMI compared to the healthy control group (all p < 0.05). In females, the T1DM group showed significantly higher levels of intracellular water, protein, minerals, skeletal muscle, fat-free mass, right leg lean mass, basal metabolic rate, and SMI, while demonstrating significantly lower body fat, body fat percentage, visceral fat area, and waist-to-hip ratio compared to the control group (all p < 0.05). Conclusion: Despite having normal or even low BMI, T1DM patients present a unique body composition profile characterized by “low fat mass, low visceral fat, but relatively high skeletal muscle mass.” This suggests that the disease state may influence energy metabolism and body composition.
- 21 April 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1776074
Open AccessAnalysis of body composition characteristics in patients with type 1 diabetes mellitus: a case–control study based on a bioelectrical impedance analyzer
Objective: This study aimed to systematically compare differences in body composition between adult patients with type 1 diabetes mellitus (T1DM) and healthy controls using the bioelectrical impedance analysis (BIA) method, to provide an objective basis for clinical nutritional assessment and intervention in T1DM patients. Methods: A total of 57 T1DM patients hospitalized at the First People’s Hospital of Yunnan Province between December 2023 and April 2024 were selected as the study group, and 55 healthy adults matched for age, sex, and BMI were recruited as the control group. Body composition indicators, including body fat, fat-free mass, skeletal muscle, visceral fat area, and phase angle (PA), were measured for all subjects using a body composition analyzer, and the skeletal muscle mass index (SMI) was calculated. BIA was used to determine body composition parameters, and statistical analyses were conducted to compare the differences between the two groups. Results: In males, the T1DM group exhibited significantly lower body fat, body fat percentage, bone mineral content, visceral fat area, and SMI compared to the healthy control group (all p < 0.05). In females, the T1DM group showed significantly higher levels of intracellular water, protein, minerals, skeletal muscle, fat-free mass, right leg lean mass, basal metabolic rate, and SMI, while demonstrating significantly lower body fat, body fat percentage, visceral fat area, and waist-to-hip ratio compared to the control group (all p < 0.05). Conclusion: Despite having normal or even low BMI, T1DM patients present a unique body composition profile characterized by “low fat mass, low visceral fat, but relatively high skeletal muscle mass.” This suggests that the disease state may influence energy metabolism and body composition.
- Open Access
- 26 February 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1793935
Phase angle as an early-warning indicator of glycaemic control in adults with type 1 diabetes mellitus: a cross-sectional study
Background: For patients with poor glycemic control of adult type 1 diabetes mellitus (T1DM), in addition to managing blood glucose levels, it is worth exploring further as an early warning indicator of blood glucose control. Methods: 56 adults with T1DM, aged between 18 and 70 years, were included in the study. Data on body composition and laboratory indicators, including phase angle values and HbA1c levels, were collected. Statistical analysis was conducted to determine the correlation and the strength of association between the phase angle, and HbA1c levels. Results: Pearson’s correlation and linear regression models indicated a negative correlation between phase angle and HbA1c levels, even after controlling for age and weight in both males and females. Conclusion: The results indicate a significant negative relationship between Phase angle and HbA1c levels. Beyond being a simple body composition parameter, Phase angle can be used as a clinical indicator of improved blood glucose control.
- 26 February 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1793935
Open AccessPhase angle as an early-warning indicator of glycaemic control in adults with type 1 diabetes mellitus: a cross-sectional study
Background: For patients with poor glycemic control of adult type 1 diabetes mellitus (T1DM), in addition to managing blood glucose levels, it is worth exploring further as an early warning indicator of blood glucose control. Methods: 56 adults with T1DM, aged between 18 and 70 years, were included in the study. Data on body composition and laboratory indicators, including phase angle values and HbA1c levels, were collected. Statistical analysis was conducted to determine the correlation and the strength of association between the phase angle, and HbA1c levels. Results: Pearson’s correlation and linear regression models indicated a negative correlation between phase angle and HbA1c levels, even after controlling for age and weight in both males and females. Conclusion: The results indicate a significant negative relationship between Phase angle and HbA1c levels. Beyond being a simple body composition parameter, Phase angle can be used as a clinical indicator of improved blood glucose control.
- 17 November 2025
- Published by Springer Nature in International Journal of Obesity
- Vol. 50 (2) , 414-420
Plasma metabolites may inhibit childhood obesity by regulating ferroptosis through SMPD1 and SIRT3
Objective To investigate the causal relationship between plasma metabolites and ferroptosis-related genes in childhood obesity and to explore the potential mediating role of ferroptosis-related genes in the association between plasma metabolites and childhood obesity risk. Methods A bidirectional two-step Mendelian randomization (MR) approach was applied, leveraging publicly available genome-wide association study (GWAS) datasets to analyze the causal relationship among 1400 plasma metabolites, 159 ferroptosis-related genes, and childhood obesity. In the first step, protein quantitative trait loci (pQTL) data corresponding to ferroptosis-related genes were identified as mediators to evaluate the causal effects of plasma metabolites and ferroptosis-related genes on childhood obesity. In the second step, MR analysis was conducted on ferroptosis-related genes and plasma metabolites identified in the first step to confirm their causal association. The inverse-variance weighted (IVW) method was primarily used for meta-analysis, while MR-PRESSO was employed to detect pleiotropy and outliers. Results Four ferroptosis-related genes (SMPD1 and SIRT3 suppressing obesity, GSTZ1 and ADAMTS13 promoting obesity) and nine plasma metabolites were found to be significantly associated with childhood obesity (six negatively correlated and three positively correlated). Further mediation analysis indicated that the ferroptosis mechanism regulated by SMPD1 and SIRT3 partially mediated the association between specific plasma metabolites and childhood obesity, with the highest mediation proportion reaching 9.62%. Sensitivity analysis confirmed the robustness of the results (no heterogeneity or horizontal pleiotropy), and reverse Mendelian randomization ruled out causal interference. Conclusion This study is the first to reveal, through Mendelian randomization analysis, the potential mediating role of ferroptosis-related genes in the association between plasma metabolites and childhood obesity. It suggests that the ferroptosis mechanism may influence childhood obesity risk by regulating specific metabolites. These findings contribute to understanding the role of ferroptosis in the pathological mechanisms of childhood obesity and provide novel molecular targets and intervention strategies for obesity prevention and treatment in children.
- 17 November 2025
- Published by Springer Nature in International Journal of Obesity
- Vol. 50 (2) , 414-420
Plasma metabolites may inhibit childhood obesity by regulating ferroptosis through SMPD1 and SIRT3
Objective To investigate the causal relationship between plasma metabolites and ferroptosis-related genes in childhood obesity and to explore the potential mediating role of ferroptosis-related genes in the association between plasma metabolites and childhood obesity risk. Methods A bidirectional two-step Mendelian randomization (MR) approach was applied, leveraging publicly available genome-wide association study (GWAS) datasets to analyze the causal relationship among 1400 plasma metabolites, 159 ferroptosis-related genes, and childhood obesity. In the first step, protein quantitative trait loci (pQTL) data corresponding to ferroptosis-related genes were identified as mediators to evaluate the causal effects of plasma metabolites and ferroptosis-related genes on childhood obesity. In the second step, MR analysis was conducted on ferroptosis-related genes and plasma metabolites identified in the first step to confirm their causal association. The inverse-variance weighted (IVW) method was primarily used for meta-analysis, while MR-PRESSO was employed to detect pleiotropy and outliers. Results Four ferroptosis-related genes (SMPD1 and SIRT3 suppressing obesity, GSTZ1 and ADAMTS13 promoting obesity) and nine plasma metabolites were found to be significantly associated with childhood obesity (six negatively correlated and three positively correlated). Further mediation analysis indicated that the ferroptosis mechanism regulated by SMPD1 and SIRT3 partially mediated the association between specific plasma metabolites and childhood obesity, with the highest mediation proportion reaching 9.62%. Sensitivity analysis confirmed the robustness of the results (no heterogeneity or horizontal pleiotropy), and reverse Mendelian randomization ruled out causal interference. Conclusion This study is the first to reveal, through Mendelian randomization analysis, the potential mediating role of ferroptosis-related genes in the association between plasma metabolites and childhood obesity. It suggests that the ferroptosis mechanism may influence childhood obesity risk by regulating specific metabolites. These findings contribute to understanding the role of ferroptosis in the pathological mechanisms of childhood obesity and provide novel molecular targets and intervention strategies for obesity prevention and treatment in children.
- 25 September 2025
- Published by Springer Nature in Pediatric Research
- Vol. 99 (4) , 1478-1484
Causal relationship between gut microbiota and blood metabolites with childhood Obesity: a Mendelian randomization study
Background This study aims to explore the causal relationship between gut microbiota and childhood obesity and to assess the potential mediating role of blood metabolites in this relationship. Methods This study covering 473 gut microbiota and 1400 metabolites. The bidirectional two-sample Mendelian Randomization method is employed, with Inverse Variance Weighted as the main statistical approach, to assess the causal relationships between gut microbiota, metabolites and Childhood Obesity. Results The study found significant causal associations between 12 types of gut microbiota and childhood obesity, with 7 microbiota showing a negative correlation and 5 acting as risk factors for obesity. Bacillaceae A showed the strongest association with childhood obesity (OR = 0.0481, P = 0.0126), while Eubacterium Q was identified as a major risk bacterium for obesity (OR = 5.4330, P = 0.0452). Additionally, 18 metabolites were found to be associated with childhood obesity, with 6-bromotryptophan being the strongest negatively correlated metabolite (OR = 0.5680, P = 0.00023) and methylsuccinate being the strongest positively correlated risk metabolite (OR = 1.6987, P = 0.0383). Mediation analysis identified 10 significant pathways, highlighting Adrenate (22:4n6) as a mediator for the gut microbiota UBA2922 sp900313925 in promoting childhood obesity (mediation effect: 0.106, mediation proportion: 10.94%), and X-12830 as a mediator for K10 sp001941205 in inhibiting childhood obesity (mediation effect: −0.0772, mediation proportion: 13.68%). Conclusion This study provides novel evidence of the causal roles of gut microbiota and blood metabolites in childhood obesity. The identification of key metabolites mediating the effects of gut microbiota on obesity risk offers potential targets for future interventions and therapeutic strategies. Impact Analysis revealed 12 gut microbiota causally related to childhood obesity, with seven negatively correlated and five identified as risk factors. Bacillaceae A (protective) and Eubacterium Q (risk) were notably associated. Among 1400 metabolites studied, 18 showed causal relationships with obesity, notably 6-bromotryptophan (protective) and methylsuccinate (risk factor). Mediation analysis identified 10 significant causal pairings between gut microbiota and blood metabolites, with Adrenate (22:4n6) mediating the promotion of childhood obesity by UBA2922 sp900313925, and X-12830 mediating the inhibition of childhood obesity by K10 sp001941205.
- 25 September 2025
- Published by Springer Nature in Pediatric Research
- Vol. 99 (4) , 1478-1484
Causal relationship between gut microbiota and blood metabolites with childhood Obesity: a Mendelian randomization study
Background This study aims to explore the causal relationship between gut microbiota and childhood obesity and to assess the potential mediating role of blood metabolites in this relationship. Methods This study covering 473 gut microbiota and 1400 metabolites. The bidirectional two-sample Mendelian Randomization method is employed, with Inverse Variance Weighted as the main statistical approach, to assess the causal relationships between gut microbiota, metabolites and Childhood Obesity. Results The study found significant causal associations between 12 types of gut microbiota and childhood obesity, with 7 microbiota showing a negative correlation and 5 acting as risk factors for obesity. Bacillaceae A showed the strongest association with childhood obesity (OR = 0.0481, P = 0.0126), while Eubacterium Q was identified as a major risk bacterium for obesity (OR = 5.4330, P = 0.0452). Additionally, 18 metabolites were found to be associated with childhood obesity, with 6-bromotryptophan being the strongest negatively correlated metabolite (OR = 0.5680, P = 0.00023) and methylsuccinate being the strongest positively correlated risk metabolite (OR = 1.6987, P = 0.0383). Mediation analysis identified 10 significant pathways, highlighting Adrenate (22:4n6) as a mediator for the gut microbiota UBA2922 sp900313925 in promoting childhood obesity (mediation effect: 0.106, mediation proportion: 10.94%), and X-12830 as a mediator for K10 sp001941205 in inhibiting childhood obesity (mediation effect: −0.0772, mediation proportion: 13.68%). Conclusion This study provides novel evidence of the causal roles of gut microbiota and blood metabolites in childhood obesity. The identification of key metabolites mediating the effects of gut microbiota on obesity risk offers potential targets for future interventions and therapeutic strategies. Impact Analysis revealed 12 gut microbiota causally related to childhood obesity, with seven negatively correlated and five identified as risk factors. Bacillaceae A (protective) and Eubacterium Q (risk) were notably associated. Among 1400 metabolites studied, 18 showed causal relationships with obesity, notably 6-bromotryptophan (protective) and methylsuccinate (risk factor). Mediation analysis identified 10 significant causal pairings between gut microbiota and blood metabolites, with Adrenate (22:4n6) mediating the promotion of childhood obesity by UBA2922 sp900313925, and X-12830 mediating the inhibition of childhood obesity by K10 sp001941205.
- Open Access
- 15 September 2025
- Published by Springer Nature in Discover Medicine
- Vol. 2 (1) , 1-11
Bidirectional two sample Mendelian randomization study on causal effects of gut microbiota and ferroptosis on Kawasaki disease with mediation analysis
- 15 September 2025
- Published by Springer Nature in Discover Medicine
- Vol. 2 (1) , 1-11
Open AccessBidirectional two sample Mendelian randomization study on causal effects of gut microbiota and ferroptosis on Kawasaki disease with mediation analysis
- Open Access
- 21 May 2025
- Published by The Royal Society in Royal Society Open Science
- Vol. 12 (5)
Causal relationship between gut microbiota, blood metabolites and autism spectrum disorder: a Mendelian randomization study
This study explored the causal relationships between gut microbiota, blood metabolites and autism spectrum disorder (ASD) in children and assessed whether metabolites mediate the relationship between microbiota and ASD. Using Mendelian randomization (MR), causal links between gut microbiota, blood metabolites and ASD were analysed, alongside reverse MR to examine reverse causality. A two-step MR mediation analysis was used to assess metabolite mediation. The study identified 15 gut microbiota types significantly associated with ASD, with Marinilabiliaceae showing the strongest positive link (odds ratio (OR) = 5.206, 95% confidence interval (CI) = 1.2783–21.2017, p = 0.0213) and Poseidoniaceae the strongest negative association (OR = 0.1466, 95% CI = 0.0306–0.7035, p = 0.0164). Among 52 blood metabolites, 4-methylcatechol sulphate was positively associated with ASD risk (OR = 1.6776, 95% CI = 1.0482–2.6849, p = 0.0311), while the glucose-to-maltose ratio showed a negative relationship (OR = 0.6358). No significant reverse causal effects of ASD on microbiota or metabolites were found. Nine metabolites mediated the relationship between microbiota and ASD, with 1-methyl-5-imidazoleacetate showing the strongest negative mediation effect (mediating effect = −0.0862, mediation proportion = 12.30%). This study reveals complex causal pathways involving microbiota and metabolites in ASD, suggesting metabolites may mediate the microbiota–ASD relationship, offering insights into ASD mechanisms and potential interventions.
- 21 May 2025
- Published by The Royal Society in Royal Society Open Science
- Vol. 12 (5)
Open AccessCausal relationship between gut microbiota, blood metabolites and autism spectrum disorder: a Mendelian randomization study
This study explored the causal relationships between gut microbiota, blood metabolites and autism spectrum disorder (ASD) in children and assessed whether metabolites mediate the relationship between microbiota and ASD. Using Mendelian randomization (MR), causal links between gut microbiota, blood metabolites and ASD were analysed, alongside reverse MR to examine reverse causality. A two-step MR mediation analysis was used to assess metabolite mediation. The study identified 15 gut microbiota types significantly associated with ASD, with Marinilabiliaceae showing the strongest positive link (odds ratio (OR) = 5.206, 95% confidence interval (CI) = 1.2783–21.2017, p = 0.0213) and Poseidoniaceae the strongest negative association (OR = 0.1466, 95% CI = 0.0306–0.7035, p = 0.0164). Among 52 blood metabolites, 4-methylcatechol sulphate was positively associated with ASD risk (OR = 1.6776, 95% CI = 1.0482–2.6849, p = 0.0311), while the glucose-to-maltose ratio showed a negative relationship (OR = 0.6358). No significant reverse causal effects of ASD on microbiota or metabolites were found. Nine metabolites mediated the relationship between microbiota and ASD, with 1-methyl-5-imidazoleacetate showing the strongest negative mediation effect (mediating effect = −0.0862, mediation proportion = 12.30%). This study reveals complex causal pathways involving microbiota and metabolites in ASD, suggesting metabolites may mediate the microbiota–ASD relationship, offering insights into ASD mechanisms and potential interventions.
- Open Access
- 30 April 2025
- Published by Springer Nature in Research Square
Plasma metabolites may inhibit childhood obesity by regulating ferroptosis through SMPD1 and SIRT3
Objective To investigate the causal relationship between plasma metabolites and ferroptosis-related genes in childhood obesity and to explore the potential mediating role of ferroptosis-related genes in the association between plasma metabolites and childhood obesity risk. Methods A bidirectional two-step Mendelian randomization (MR) approach was applied, leveraging publicly available genome-wide association study (GWAS) datasets to analyze the causal relationship among 1,400 plasma metabolites, 159 ferroptosis-related genes, and childhood obesity. In the first step, protein quantitative trait loci (pQTL) data corresponding to ferroptosis-related genes were identified as mediators to evaluate the causal effects of plasma metabolites and ferroptosis-related genes on childhood obesity. In the second step, MR analysis was conducted on ferroptosis-related genes and plasma metabolites identified in the first step to confirm their causal association. The inverse-variance weighted (IVW) method was primarily used for meta-analysis, while MR-PRESSO was employed to detect pleiotropy and outliers. Results Four ferroptosis-related genes (SMPD1 and SIRT3 suppressing obesity, GSTZ1 and ADAMTS13 promoting obesity) and nine plasma metabolites were found to be significantly associated with childhood obesity (six negatively correlated and three positively correlated). Further mediation analysis indicated that the ferroptosis mechanism regulated by SMPD1 and SIRT3 partially mediated the association between specific plasma metabolites and childhood obesity, with the highest mediation proportion reaching 9.62%. Sensitivity analysis confirmed the robustness of the results (no heterogeneity or horizontal pleiotropy), and reverse Mendelian randomization ruled out causal interference. Conclusion This study is the first to reveal, through Mendelian randomization analysis, the potential mediating role of ferroptosis-related genes in the association between plasma metabolites and childhood obesity. It suggests that the ferroptosis mechanism may influence childhood obesity risk by regulating specific metabolites. These findings contribute to understanding the role of ferroptosis in the pathological mechanisms of childhood obesity and provide novel molecular targets and intervention strategies for obesity prevention and treatment in children.
- 30 April 2025
- Published by Springer Nature in Research Square
Open AccessPlasma metabolites may inhibit childhood obesity by regulating ferroptosis through SMPD1 and SIRT3
Objective To investigate the causal relationship between plasma metabolites and ferroptosis-related genes in childhood obesity and to explore the potential mediating role of ferroptosis-related genes in the association between plasma metabolites and childhood obesity risk. Methods A bidirectional two-step Mendelian randomization (MR) approach was applied, leveraging publicly available genome-wide association study (GWAS) datasets to analyze the causal relationship among 1,400 plasma metabolites, 159 ferroptosis-related genes, and childhood obesity. In the first step, protein quantitative trait loci (pQTL) data corresponding to ferroptosis-related genes were identified as mediators to evaluate the causal effects of plasma metabolites and ferroptosis-related genes on childhood obesity. In the second step, MR analysis was conducted on ferroptosis-related genes and plasma metabolites identified in the first step to confirm their causal association. The inverse-variance weighted (IVW) method was primarily used for meta-analysis, while MR-PRESSO was employed to detect pleiotropy and outliers. Results Four ferroptosis-related genes (SMPD1 and SIRT3 suppressing obesity, GSTZ1 and ADAMTS13 promoting obesity) and nine plasma metabolites were found to be significantly associated with childhood obesity (six negatively correlated and three positively correlated). Further mediation analysis indicated that the ferroptosis mechanism regulated by SMPD1 and SIRT3 partially mediated the association between specific plasma metabolites and childhood obesity, with the highest mediation proportion reaching 9.62%. Sensitivity analysis confirmed the robustness of the results (no heterogeneity or horizontal pleiotropy), and reverse Mendelian randomization ruled out causal interference. Conclusion This study is the first to reveal, through Mendelian randomization analysis, the potential mediating role of ferroptosis-related genes in the association between plasma metabolites and childhood obesity. It suggests that the ferroptosis mechanism may influence childhood obesity risk by regulating specific metabolites. These findings contribute to understanding the role of ferroptosis in the pathological mechanisms of childhood obesity and provide novel molecular targets and intervention strategies for obesity prevention and treatment in children.
- Open Access
- 3 April 2025
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 13, 1558099
Risk factors for hemorrhagic cystitis in children with severe beta-thalassemia after allogeneic hematopoietic stem cell transplantation
Purpose: To investigate the risk factors for hemorrhagic cystitis (HC) in children with severe beta-thalassemia after allogeneic hematopoietic stem cell transplantation (allo-HSCT).Methods: The clinical data of 152 children under the age of 15 who underwent allo-HSCT between January 2011 and December 2021 were retrospectively analyzed. The incidence of HC and related variables were evaluated using univariate analysis. Variables with statistical significance (P < 0.05) were included in a multivariable logistic regression model to identify independent risk factors for HC.Results: Among the 152 children, 42 developed HC, with an incidence rate of 27.63%. The median onset time of HC was 25 days (IQR: 10–38.75 days). Univariate analysis indicated that older transplantation age, elevated pre-transplant serum ferritin levels, cytomegalovirus (CMV) infection, and prolonged neutrophil engraftment time were associated with HC occurrence (P < 0.05). Multivariable logistic regression further confirmed that older transplantation age (OR 1.236, 95% CI: 1.031–1.531, P = 0.033), elevated pre-transplant ferritin levels (OR 1.053, 95% CI: 1.028–1.086, P < 0.01), CMV infection (OR 11.522, 95% CI: 2.912–76.345, P = 0.002), and prolonged neutrophil engraftment time (OR 1.385, 95% CI: 1.109–1.793, P < 0.01) were independent risk factors for HC.Conclusion: Older transplantation age (>5.95 age years old), elevated pre-transplant serum ferritin levels, CMV infection, and delayed neutrophil engraftment are independent risk factors for HC in children with severe beta-thalassemia after allo-HSCT. Early identification and intervention for these risk factors are crucial in reducing the incidence of HC.
- 3 April 2025
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 13, 1558099
Open AccessRisk factors for hemorrhagic cystitis in children with severe beta-thalassemia after allogeneic hematopoietic stem cell transplantation
Purpose: To investigate the risk factors for hemorrhagic cystitis (HC) in children with severe beta-thalassemia after allogeneic hematopoietic stem cell transplantation (allo-HSCT).Methods: The clinical data of 152 children under the age of 15 who underwent allo-HSCT between January 2011 and December 2021 were retrospectively analyzed. The incidence of HC and related variables were evaluated using univariate analysis. Variables with statistical significance (P < 0.05) were included in a multivariable logistic regression model to identify independent risk factors for HC.Results: Among the 152 children, 42 developed HC, with an incidence rate of 27.63%. The median onset time of HC was 25 days (IQR: 10–38.75 days). Univariate analysis indicated that older transplantation age, elevated pre-transplant serum ferritin levels, cytomegalovirus (CMV) infection, and prolonged neutrophil engraftment time were associated with HC occurrence (P < 0.05). Multivariable logistic regression further confirmed that older transplantation age (OR 1.236, 95% CI: 1.031–1.531, P = 0.033), elevated pre-transplant ferritin levels (OR 1.053, 95% CI: 1.028–1.086, P < 0.01), CMV infection (OR 11.522, 95% CI: 2.912–76.345, P = 0.002), and prolonged neutrophil engraftment time (OR 1.385, 95% CI: 1.109–1.793, P < 0.01) were independent risk factors for HC.Conclusion: Older transplantation age (>5.95 age years old), elevated pre-transplant serum ferritin levels, CMV infection, and delayed neutrophil engraftment are independent risk factors for HC in children with severe beta-thalassemia after allo-HSCT. Early identification and intervention for these risk factors are crucial in reducing the incidence of HC.